CII elects R Mukundan as President for 2026-27, Suchitra K Ella named President-Designate
Shashwat Goenka takes over as Vice President of industry body
Shashwat Goenka takes over as Vice President of industry body
The event will bring together industrial leaders, technology providers, and policymakers to discuss real-world Industrial AI applications in Bangalore
With 267 million tobacco users, improving access to evidence-based cessation tools is seen as critical
The private funding rose 38% amid growing international collaborations and CDMO demand
The ISG assessment highlights Indegene’s deep domain expertise, proprietary technology stack, and expanding use of AI and GenAI to drive more integrated, data-led commercial execution across the life sciences value chain
His appointment is expected to further strengthen the company’s financial governance and regional operational strategy across South Asia
Our company remains focused on advancing monoclonal antibody therapeutics for solid tumors, with a clear emphasis on combination immunotherapy strategies
Ajax's lead program, AJ1-11095, is a first-in-class Type II JAK2 inhibitor currently in Phase 1 clinical development, with first proof-of-concept clinical data to be presented later in 2026
Former Cipla MD & CEO to lead next phase of growth at science-led CDMO platform; Vivek Sharma transitions to advisory role
Subscribe To Our Newsletter & Stay Updated